Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the company provides entertainment products. It offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Tilray Craft,…
| Quarter | Revenue | YoY | Net Income | EPS (dil.) | YoY | Gross Margin | Op. Margin |
|---|---|---|---|---|---|---|---|
| Q 2026 Feb 2026 | $206.7M | — | $-26.6M | $-0.24 | — | 26.6% | -9.6% |
| Q 2025 Nov 2025 | $217.5M | — | $-44.9M | $-0.41 | — | 26.4% | -9.2% |
| Q 2025 Aug 2025 | $209.5M | — | $-322,000 | $0.00 | — | 27.4% | -5.2% |
| Q 2025 May 2025 | $224.5M | — | $-1.27B | $-13.00 | — | 30.1% | -5.6% |
| Q 2025 Feb 2025 | $185.8M | — | $-789.4M | $-8.70 | — | 28.0% | -16.9% |
Data from Yahoo Finance. YoY compares the same quarter of the prior fiscal year.
Tilray Brands strategy review: $837M revenue, aggressive acquisitions, significant dilution – turnaround opportunity or warning signal?